Copyright Reports & Markets. All rights reserved.

Global and Japan Pancreatic Beta-Cell Protection Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Pancreatic Beta-Cell Protection Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 Stem Cell Based
    • 1.2.3 Gene Therapies
    • 1.2.4 RNA Based Therapies
    • 1.2.5 Monoclonal Antibodies (MAbs)
    • 1.2.6 Phytotherapy
  • 1.3 Market by Application
    • 1.3.1 Global Pancreatic Beta-Cell Protection Market Share by Application: 2020 VS 2026
    • 1.3.2 Hospital
    • 1.3.3 Medical Research Laboratory
    • 1.3.4 Others
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Pancreatic Beta-Cell Protection Market Perspective (2015-2026)
  • 2.2 Global Pancreatic Beta-Cell Protection Growth Trends by Regions
    • 2.2.1 Pancreatic Beta-Cell Protection Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Pancreatic Beta-Cell Protection Historic Market Share by Regions (2015-2020)
    • 2.2.3 Pancreatic Beta-Cell Protection Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Pancreatic Beta-Cell Protection Players by Market Size
    • 3.1.1 Global Top Pancreatic Beta-Cell Protection Players by Revenue (2015-2020)
    • 3.1.2 Global Pancreatic Beta-Cell Protection Revenue Market Share by Players (2015-2020)
  • 3.2 Global Pancreatic Beta-Cell Protection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Pancreatic Beta-Cell Protection Revenue
  • 3.4 Global Pancreatic Beta-Cell Protection Market Concentration Ratio
    • 3.4.1 Global Pancreatic Beta-Cell Protection Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Pancreatic Beta-Cell Protection Revenue in 2019
  • 3.5 Key Players Pancreatic Beta-Cell Protection Area Served
  • 3.6 Key Players Pancreatic Beta-Cell Protection Product Solution and Service
  • 3.7 Date of Enter into Pancreatic Beta-Cell Protection Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Pancreatic Beta-Cell Protection Breakdown Data by Type (2015-2026)

  • 4.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Type (2015-2020)
  • 4.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Type (2021-2026)

5 Pancreatic Beta-Cell Protection Breakdown Data by Application (2015-2026)

  • 5.1 Global Pancreatic Beta-Cell Protection Historic Market Size by Application (2015-2020)
  • 5.2 Global Pancreatic Beta-Cell Protection Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Pancreatic Beta-Cell Protection Market Size (2015-2026)
  • 6.2 North America Pancreatic Beta-Cell Protection Market Size by Type (2015-2020)
  • 6.3 North America Pancreatic Beta-Cell Protection Market Size by Application (2015-2020)
  • 6.4 North America Pancreatic Beta-Cell Protection Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Pancreatic Beta-Cell Protection Market Size (2015-2026)
  • 7.2 Europe Pancreatic Beta-Cell Protection Market Size by Type (2015-2020)
  • 7.3 Europe Pancreatic Beta-Cell Protection Market Size by Application (2015-2020)
  • 7.4 Europe Pancreatic Beta-Cell Protection Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Pancreatic Beta-Cell Protection Market Size (2015-2026)
  • 8.2 China Pancreatic Beta-Cell Protection Market Size by Type (2015-2020)
  • 8.3 China Pancreatic Beta-Cell Protection Market Size by Application (2015-2020)
  • 8.4 China Pancreatic Beta-Cell Protection Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Pancreatic Beta-Cell Protection Market Size (2015-2026)
  • 9.2 Japan Pancreatic Beta-Cell Protection Market Size by Type (2015-2020)
  • 9.3 Japan Pancreatic Beta-Cell Protection Market Size by Application (2015-2020)
  • 9.4 Japan Pancreatic Beta-Cell Protection Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Pancreatic Beta-Cell Protection Market Size (2015-2026)
  • 10.2 Southeast Asia Pancreatic Beta-Cell Protection Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Pancreatic Beta-Cell Protection Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Pancreatic Beta-Cell Protection Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11 Key Players Profiles

  • 11.1 ViaCyte
    • 11.1.1 ViaCyte Company Details
    • 11.1.2 ViaCyte Business Overview
    • 11.1.3 ViaCyte Pancreatic Beta-Cell Protection Introduction
    • 11.1.4 ViaCyte Revenue in Pancreatic Beta-Cell Protection Business (2015-2020))
    • 11.1.5 ViaCyte Recent Development
  • 11.2 PharmaCyte Biotech
    • 11.2.1 PharmaCyte Biotech Company Details
    • 11.2.2 PharmaCyte Biotech Business Overview
    • 11.2.3 PharmaCyte Biotech Pancreatic Beta-Cell Protection Introduction
    • 11.2.4 PharmaCyte Biotech Revenue in Pancreatic Beta-Cell Protection Business (2015-2020)
    • 11.2.5 PharmaCyte Biotech Recent Development
  • 11.3 Boehringer Ingelheim
    • 11.3.1 Boehringer Ingelheim Company Details
    • 11.3.2 Boehringer Ingelheim Business Overview
    • 11.3.3 Boehringer Ingelheim Pancreatic Beta-Cell Protection Introduction
    • 11.3.4 Boehringer Ingelheim Revenue in Pancreatic Beta-Cell Protection Business (2015-2020)
    • 11.3.5 Boehringer Ingelheim Recent Development
  • 11.4 GalaxoSmithKline
    • 11.4.1 GalaxoSmithKline Company Details
    • 11.4.2 GalaxoSmithKline Business Overview
    • 11.4.3 GalaxoSmithKline Pancreatic Beta-Cell Protection Introduction
    • 11.4.4 GalaxoSmithKline Revenue in Pancreatic Beta-Cell Protection Business (2015-2020)
    • 11.4.5 GalaxoSmithKline Recent Development
  • 11.5 Beta-Cell NV
    • 11.5.1 Beta-Cell NV Company Details
    • 11.5.2 Beta-Cell NV Business Overview
    • 11.5.3 Beta-Cell NV Pancreatic Beta-Cell Protection Introduction
    • 11.5.4 Beta-Cell NV Revenue in Pancreatic Beta-Cell Protection Business (2015-2020)
    • 11.5.5 Beta-Cell NV Recent Development
  • 11.6 Novartis
    • 11.6.1 Novartis Company Details
    • 11.6.2 Novartis Business Overview
    • 11.6.3 Novartis Pancreatic Beta-Cell Protection Introduction
    • 11.6.4 Novartis Revenue in Pancreatic Beta-Cell Protection Business (2015-2020)
    • 11.6.5 Novartis Recent Development
  • 11.7 Janssen Research & Development
    • 11.7.1 Janssen Research & Development Company Details
    • 11.7.2 Janssen Research & Development Business Overview
    • 11.7.3 Janssen Research & Development Pancreatic Beta-Cell Protection Introduction
    • 11.7.4 Janssen Research & Development Revenue in Pancreatic Beta-Cell Protection Business (2015-2020)
    • 11.7.5 Janssen Research & Development Recent Development
  • 11.8 Pfizer Inc
    • 11.8.1 Pfizer Inc Company Details
    • 11.8.2 Pfizer Inc Business Overview
    • 11.8.3 Pfizer Inc Pancreatic Beta-Cell Protection Introduction
    • 11.8.4 Pfizer Inc Revenue in Pancreatic Beta-Cell Protection Business (2015-2020)
    • 11.8.5 Pfizer Inc Recent Development
  • 11.9 BioLineRx
    • 11.9.1 BioLineRx Company Details
    • 11.9.2 BioLineRx Business Overview
    • 11.9.3 BioLineRx Pancreatic Beta-Cell Protection Introduction
    • 11.9.4 BioLineRx Revenue in Pancreatic Beta-Cell Protection Business (2015-2020)
    • 11.9.5 BioLineRx Recent Development
  • 11.10 Genentech
    • 11.10.1 Genentech Company Details
    • 11.10.2 Genentech Business Overview
    • 11.10.3 Genentech Pancreatic Beta-Cell Protection Introduction
    • 11.10.4 Genentech Revenue in Pancreatic Beta-Cell Protection Business (2015-2020)
    • 11.10.5 Genentech Recent Development
  • 11.11 Novo Nordisk
    • 10.11.1 Novo Nordisk Company Details
    • 10.11.2 Novo Nordisk Business Overview
    • 10.11.3 Novo Nordisk Pancreatic Beta-Cell Protection Introduction
    • 10.11.4 Novo Nordisk Revenue in Pancreatic Beta-Cell Protection Business (2015-2020)
    • 10.11.5 Novo Nordisk Recent Development
  • 11.12 Sanofi
    • 10.12.1 Sanofi Company Details
    • 10.12.2 Sanofi Business Overview
    • 10.12.3 Sanofi Pancreatic Beta-Cell Protection Introduction
    • 10.12.4 Sanofi Revenue in Pancreatic Beta-Cell Protection Business (2015-2020)
    • 10.12.5 Sanofi Recent Development
  • 11.13 Osiris Therapeutics
    • 10.13.1 Osiris Therapeutics Company Details
    • 10.13.2 Osiris Therapeutics Business Overview
    • 10.13.3 Osiris Therapeutics Pancreatic Beta-Cell Protection Introduction
    • 10.13.4 Osiris Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2015-2020)
    • 10.13.5 Osiris Therapeutics Recent Development
  • 11.14 Beta-O2 Technologies Ltd
    • 10.14.1 Beta-O2 Technologies Ltd Company Details
    • 10.14.2 Beta-O2 Technologies Ltd Business Overview
    • 10.14.3 Beta-O2 Technologies Ltd Pancreatic Beta-Cell Protection Introduction
    • 10.14.4 Beta-O2 Technologies Ltd Revenue in Pancreatic Beta-Cell Protection Business (2015-2020)
    • 10.14.5 Beta-O2 Technologies Ltd Recent Development
  • 11.15 Transition Therapeutics
    • 10.15.1 Transition Therapeutics Company Details
    • 10.15.2 Transition Therapeutics Business Overview
    • 10.15.3 Transition Therapeutics Pancreatic Beta-Cell Protection Introduction
    • 10.15.4 Transition Therapeutics Revenue in Pancreatic Beta-Cell Protection Business (2015-2020)
    • 10.15.5 Transition Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

    13 Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Global Pancreatic Beta-Cell Protection Scope and Market Size
    Pancreatic Beta-Cell Protection market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Pancreatic Beta-Cell Protection market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    Stem Cell Based
    Gene Therapies
    RNA Based Therapies
    Monoclonal Antibodies (MAbs)
    Phytotherapy

    Market segment by Application, split into
    Hospital
    Medical Research Laboratory
    Others

    Based on regional and country-level analysis, the Pancreatic Beta-Cell Protection market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Pancreatic Beta-Cell Protection market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    ViaCyte
    PharmaCyte Biotech
    Boehringer Ingelheim
    GalaxoSmithKline
    Beta-Cell NV
    Novartis
    Janssen Research & Development
    Pfizer Inc
    BioLineRx
    Genentech
    Novo Nordisk
    Sanofi
    Osiris Therapeutics
    Beta-O2 Technologies Ltd
    Transition Therapeutics

    Buy now